These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 14607791)

  • 1. Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction.
    Hassan A; Hunt BJ; O'Sullivan M; Bell R; D'Souza R; Jeffery S; Bamford JM; Markus HS
    Brain; 2004 Jan; 127(Pt 1):212-9. PubMed ID: 14607791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis.
    Hassan A; Hunt BJ; O'Sullivan M; Parmar K; Bamford JM; Briley D; Brown MM; Thomas DJ; Markus HS
    Brain; 2003 Feb; 126(Pt 2):424-32. PubMed ID: 12538408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mild hyperhomocysteinemia and low folate concentrations as risk factors for cervical arterial dissection.
    Arauz A; Hoyos L; Cantú C; Jara A; Martínez L; García I; Fernández Mde L; Alonso E
    Cerebrovasc Dis; 2007; 24(2-3):210-4. PubMed ID: 17596690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial function markers in parkinsonian patients with hyperhomocysteinemia.
    Bostantjopoulou S; Katsarou Z; Frangia T; Hatzizisi O; Papazisis K; Kyriazis G; Kiosseoglou G; Kazis A
    J Clin Neurosci; 2005 Aug; 12(6):669-72. PubMed ID: 16040247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperhomocysteinaemia, methylenetetrahydrofolate reductase polymorphism and risk of coronary artery disease.
    Kerkeni M; Addad F; Chauffert M; Myara A; Gerhardt M; Chevenne D; Trivin F; Farhat MB; Miled A; Maaroufi K
    Ann Clin Biochem; 2006 May; 43(Pt 3):200-6. PubMed ID: 16704755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MTHFR C677T and A1298C gene polymorphisms and hyperhomocysteinemia as risk factors of diabetic nephropathy in type 2 diabetes patients.
    Mtiraoui N; Ezzidi I; Chaieb M; Marmouche H; Aouni Z; Chaieb A; Mahjoub T; Vaxillaire M; Almawi WY
    Diabetes Res Clin Pract; 2007 Jan; 75(1):99-106. PubMed ID: 16828193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperhomocysteinemia and the methylenetetrahydrofolate reductase 677C-T mutation in patients under 50 years of age affected by central retinal vein occlusion.
    Di Crecchio L; Parodi MB; Sanguinetti G; Iacono P; Ravalico G
    Ophthalmology; 2004 May; 111(5):940-5. PubMed ID: 15121372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homocysteine, small-vessel disease, and atherosclerosis: an MRI study of 825 stroke patients.
    Jeon SB; Kang DW; Kim JS; Kwon SU
    Neurology; 2014 Aug; 83(8):695-701. PubMed ID: 25031284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperhomocysteinemia and the MTHFR C677T mutation in Budd-Chiari syndrome.
    Li XM; Wei YF; Hao HL; Hao YB; He LS; Li JD; Mei B; Wang SY; Wang C; Wang JX; Zhu JZ; Liang JQ
    Am J Hematol; 2002 Sep; 71(1):11-4. PubMed ID: 12221667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperhomocysteinemia is a risk factor of recurrent coronary event in young patients irrespective to the MTHFR C677T polymorphism.
    Gonzalez-Porras JR; Martin-Herrero F; Garcia-Sanz R; Lopez ML; Balanzategui A; Mateos MV; Pavon P; Gonzalez M; Alberca I; San Miguel JF
    Thromb Res; 2007; 119(6):691-8. PubMed ID: 17005242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylenetetrahydrofolate reductase C677T and A1298C polymorphism and changes in homocysteine concentrations in women with idiopathic recurrent pregnancy losses.
    Mtiraoui N; Zammiti W; Ghazouani L; Braham NJ; Saidi S; Finan RR; Almawi WY; Mahjoub T
    Reproduction; 2006 Feb; 131(2):395-401. PubMed ID: 16452733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperhomocysteinaemia in a young woman presenting with stroke, associated with methylene tetrahydrofolate reductase C677T homozygosity.
    Saldana Chaparro R; Barron JL
    Ann Clin Biochem; 2004 May; 41(Pt 3):241-4. PubMed ID: 15117441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High plasma homocysteine is associated with the risk of coronary artery disease independent of methylenetetrahydrofolate reductase 677C-->T genotypes.
    Lin PT; Huang MC; Lee BJ; Cheng CH; Tsai TP; Huang YC
    Asia Pac J Clin Nutr; 2008; 17(2):330-8. PubMed ID: 18586656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylenetetrahydrofolate reductase gene, homocysteine and coronary artery disease: the A1298C polymorphism does matter. Inferences from a case study (Madeira, Portugal).
    Freitas AI; Mendonça I; Guerra G; Brión M; Reis RP; Carracedo A; Brehm A
    Thromb Res; 2008; 122(5):648-56. PubMed ID: 18384842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of pre-eclampsia with hyperhomocysteinaemia and methylenetetrahydrofolate reductase gene C677T polymorphism in a Turkish population.
    Yilmaz H; Unlüçerçi Y; Gürdöl F; Isbilen E; Isbir T
    Aust N Z J Obstet Gynaecol; 2004 Oct; 44(5):423-7. PubMed ID: 15387863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinal vein occlusion, homocysteine, and methylene tetrahydrofolate reductase genotype.
    McGimpsey SJ; Woodside JV; Bamford L; Gilchrist SE; Graydon R; McKeeman GC; Young IS; Hughes AE; Patterson CC; O'Reilly D; McGibbon D; Chakravarthy U
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4712-6. PubMed ID: 16303969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 677TT polymorphism of methylenetetrahydrofolate reductase in combination with low serum vitamin B12 is associated with coronary in-stent restenosis.
    Chung SL; Chiou KR; Charng MJ
    Catheter Cardiovasc Interv; 2006 Mar; 67(3):349-55. PubMed ID: 16489563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C677T mutation of methylenetetrahydrofolate reductase gene and serum homocysteine levels in Turkish patients with coronary artery disease.
    Yilmaz H; Isbir S; Agachan B; Ergen A; Farsak B; Isbir T
    Cell Biochem Funct; 2006; 24(1):87-90. PubMed ID: 15648053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased total homocysteine level is associated with clinical status and severity of white matter changes in symptomatic patients with subcortical small vessel disease.
    Pavlovic AM; Pekmezovic T; Obrenovic R; Novakovic I; Tomic G; Mijajlovic M; Sternic N
    Clin Neurol Neurosurg; 2011 Nov; 113(9):711-5. PubMed ID: 21802199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further evidence that hyperhomocysteinemia and methylenetetrahydrofolate reductase C677T and A1289C polymorphisms are not risk factors for schizophrenia.
    Vilella E; Virgos C; Murphy M; Martorell L; Valero J; Simó JM; Joven J; Fernández-Ballart J; Labad A
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Sep; 29(7):1169-74. PubMed ID: 16076517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.